DDX53 and Cachexia: Several features of CT26 cancer‐induced cachexia, such as loss of grip strength, weakness, and muscle atrophy, were partially ameliorated by GRd (Figures4B–F and S3D–F; main effect of GRd treatment, P < 0.001).